Magenta Therapeutics: Valuation Remains Under Pressure With Lack Of Catalysts, But Promise Remains [Seeking Alpha]
Magenta Therapeutics, Inc. (MGTA)
Last magenta therapeutics, inc. earnings: 11/13 08:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Magenta Therapeutics: Valuation Remains Under Pressure With Lack Of Catalysts, But Promise Remains Summary Shares of Magenta Therapeutics (MGTA) have quieted down quite a bit since heating up in the 1Q. Since IPO, Magenta has released promising efficacy data from their lead candidate, 456. The asset, however, is not without blemish. In the article below, we take a closer look at 456. Magenta has also had to dilute investors at disadvantageous prices. Overall, Magenta appears conservatively valued in light of its broad pipeline potential. Note: The following article assumes you are familiar with my introductory article Introduction Shares opened at $15 and began trading in late June. Magenta was very vulnerable to a very weak 4Q '18 for all of biotech, dipping to all-time lows of $5/share. Magenta began a rally in January that was fortified with promising data In early May, the company raised Capital Structure Outstanding shares: 38,767,292 Cost per share: ~$11.50 Market capitalization
Show less
Read more
Impact Snapshot
Event Time:
MGTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTA alerts
High impacting Magenta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics